Artisan Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Artisan Partners’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,592	Closed	-$3.71M	–	349
2023 Q1	$3.71M	Buy	+34,592	New	+$3.98M	0.01%	306

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Artisan Partners's RXDX Position: Q2 2023 in Review

Artisan Partners sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 34,592 shares — an estimated $3.71M sold.

Artisan Partners first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $3.71M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Artisan Partners reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Artisan Partners sold 34,592 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $3.71M.
Artisan Partners first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Artisan Partners's Prometheus Biosciences, Inc. Common Stock position peaked at $3.71M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Artisan Partners's 13F filing for Q2 2023, filed 10 Aug 2023.